Institution
Rockefeller University
Education•New York, New York, United States•
About: Rockefeller University is a education organization based out in New York, New York, United States. It is known for research contribution in the topics: Population & Gene. The organization has 15867 authors who have published 32938 publications receiving 2940261 citations. The organization is also known as: Rockefeller University & Rockefeller Institute.
Topics: Population, Gene, Virus, Antigen, Receptor
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Several properties of lymphoid dendritic cells in situ have been determined, and contrasted to information previously established for lymphocytes and mononuclear phagocytes, and further distinguish dendedritic cells as a novel cell type, distinct from monon nuclear phagocyte and lymphocytes.
Abstract: Several properties of lymphoid dendritic cells in situ have been determined, and contrasted to information previously established for lymphocytes and mononuclear phagocytes. Dendritic cells are not found in newborn mice, and their concentration in both spleen and mesenteric lymph node does not reach adult levels until 3–4 wk of age. Dendritic cells largely disappear from adherent populations following administration of steroids (2.5 mg hydrocortisone acetate s.c.) and ionizing radiation (Do of 100 rads for Co60). Splenic dendritic cells can originate from precursors located in both bone marrow and spleen itself, probably the red pulp. The mature splenic population does not actively divide (pulse labeling index with [3H]thymidine of 1.5–2.5%), but does turnover at substantial rate, 10+% of the total pool per day. The influx of new cells appears to be derived from a proliferating precursor compartment, but the mechanism for efflux or turnover is not known. Dendritic cells in spleen and node undergo little or moderate increase in numbers during development of a primary immune response. These in vivo characteristics, taken together, further distinguish dendritic cells as a novel cell type, distinct from mononuclear phagocytes and lymphocytes.
642 citations
••
TL;DR: In this article, the authors measured the attenuation of white noise and pure tones between one microphone close to a loudspeaker and another microphone 100 m away, at the same height, in open fields, mixed decidous forest with and without leaves and coniferous forest in Dutchess County, New York.
Abstract: 1.
Sound transmission was measured in open fields, mixed decidous forest with and without leaves and coniferous forest in Dutchess County, New York. Attenuation of white noise and pure tones was measured between one microphone close to a loudspeaker and another microphone 100 m away, at the same height. Graphs of excess attenuation (E.A. in dB/100 m) against frequency were obtained at 0.15, 1, 2, 5, and 10 m above the ground. An analysis of variance was conducted to estimate effects of height, frequency and habitat.
2.
Height and frequency affect sound transmission more than habitat. With a sound source close to the ground (15 cm and 1 m) all frequencies were more attenuated than at greater heights. The patterns of E.A. as a function of sound frequency were basically similar in all habitats. At all source heights the lower the frequency the better the sound carried, with the exception that close to the ground, sounds below 2 kHz were excessively attenuated. Comparing open field and forest, trees improved transmission of frequencies below 3 kHz, especially close to the ground.
3.
Some general trends can be predicted for maximization of transmission distances of animal sounds in these habitats. For an animal vocalizing higher than 1 m above the ground, the lower the frequency the further the sound travels. Close to the ground, low frequencies are again preferred for maximization of transmission distances, but the frequencies must be pitched above a range of attenuated, low-pitched sounds, the limits of which vary to some extent with habitat, creating the ‘sound window’ of Morton. This ‘window’ of least-attenuated frequencies, only occurring close to the ground, tends to be pitched somewhat lower in forest than in open habitats. However, for an animal producing sounds in the habitats tested, perch height and sound frequency are more important than the habitat in determining how far the sound will carry.
641 citations
••
TL;DR: It is proposed that the MRE11 complex functions at telomeres, possibly by modulating t-loop formation, and is shown that RAD50 protein is present in TRF2 immunocomplexes.
Abstract: Telomeres allow cells to distinguish natural chromosome ends from damaged DNA and protect the ends from degradation and fusion In human cells, telomere protection depends on the TTAGGG repeat binding factor, TRF2 (refs 1-4), which has been proposed to remodel telomeres into large duplex loops (t-loops) Here we show by nanoelectrospray tandem mass spectrometry that RAD50 protein is present in TRF2 immunocomplexes Protein blotting showed that a small fraction of RAD50, MRE11 and the third component of the MRE11 double-strand break (DSB) repair complex, the Nijmegen breakage syndrome protein (NBS1), is associated with TRF2 Indirect immunofluorescence demonstrated the presence of RAD50 and MRE11 at interphase telomeres NBS1 was associated with TRF2 and telomeres in S phase, but not in G1 or G2 Although the MRE11 complex accumulated in irradiation-induced foci (IRIFs) in response to gamma-irradiation, TRF2 did not relocate to IRIFs and irradiation did not affect the association of TRF2 with the MRE11 complex, arguing against a role for TRF2 in DSB repair Instead, we propose that the MRE11 complex functions at telomeres, possibly by modulating t-loop formation
641 citations
••
TL;DR: A simple method to modify bacterial artificial chromosomes directly in the recombination-deficient E. coli host strain by homologous recombination for in vivo studies and proper expression of the lacZ transgene in the brain has been observed.
Abstract: Escherichia coli-based artificial chromosomes have become important tools for physical mapping and sequencing in various genome projects. The lack of a general method to modify these large bacterial clones, however, has limited their utility in functional studies. We developed a simple method to modify bacterial artificial chromosomes directly in the recombination-deficient E. coli host strain by homologous recombination for in vivo studies. The IRES-LacZ marker gene was introduced into a 131 kb BAC containing the murine zinc finger gene, RU49. No rearrangements or deletions were detected in the modified BACs. Furthermore, transgenic mice were generated by pronuclear injection of the modified BAC, and germline transmission of the intact BAC has been obtained. Proper expression of the lacZ transgene in the brain has been observed, which could not be obtained with conventional transgenic constructs.
640 citations
••
University of Leicester1, University of Hertfordshire2, Rockefeller University3, University of Sheffield4, Queen's University Belfast5, University of British Columbia6, University of Bedfordshire7, University of Birmingham8, St George's, University of London9, University of Brighton10, Queen Victoria Hospital11, University of Liverpool12, Norwich University13, GlaxoSmithKline14, MedImmune15, Imperial College London16, AstraZeneca17
TL;DR: This first wave of alternatives to antibiotics will probably best serve as adjunctive or preventive therapies, which suggests that conventional antibiotics are still needed.
Abstract: Antibiotics have saved countless lives and enabled the development of modern medicine over the past 70 years. However, it is clear that the success of antibiotics might only have been temporary and we now expect a long-term and perhaps never-ending challenge to find new therapies to combat antibiotic-resistant bacteria. A broader approach to address bacterial infection is needed. In this Review, we discuss alternatives to antibiotics, which we defined as non-compound approaches (products other than classic antibacterial agents) that target bacteria or any approaches that target the host. The most advanced approaches are antibodies, probiotics, and vaccines in phase 2 and phase 3 trials. This first wave of alternatives to antibiotics will probably best serve as adjunctive or preventive therapies, which suggests that conventional antibiotics are still needed. Funding of more than £1·5 billion is needed over 10 years to test and develop these alternatives to antibiotics. Investment needs to be partnered with translational expertise and targeted to support the validation of these approaches in phase 2 trials, which would be a catalyst for active engagement and investment by the pharmaceutical and biotechnology industry. Only a sustained, concerted, and coordinated international effort will provide the solutions needed for the future.
640 citations
Authors
Showing all 15925 results
Name | H-index | Papers | Citations |
---|---|---|---|
Bruce S. McEwen | 215 | 1163 | 200638 |
David Baltimore | 203 | 876 | 162955 |
Ronald M. Evans | 199 | 708 | 166722 |
Lewis C. Cantley | 196 | 748 | 169037 |
Ronald Klein | 194 | 1305 | 149140 |
Scott M. Grundy | 187 | 841 | 231821 |
Jie Zhang | 178 | 4857 | 221720 |
Andrea Bocci | 172 | 2402 | 176461 |
Ralph M. Steinman | 171 | 453 | 121518 |
Masayuki Yamamoto | 171 | 1576 | 123028 |
Zena Werb | 168 | 473 | 122629 |
Nahum Sonenberg | 167 | 647 | 104053 |
Michel C. Nussenzweig | 165 | 516 | 87665 |
Harvey F. Lodish | 165 | 782 | 101124 |
Dennis R. Burton | 164 | 683 | 90959 |